Detection of pancreatic ductal adenocarcinoma with galectin-9 serum levels

Pancreatic ductal adenocarcinoma (PDAC) responds poorly to checkpoint blockade, such as anti-CTLA-4 and anti-PD-1. Galectin-9, a β-galactoside-binding lectin, promotes immune suppression through T-cell inhibition, and programming of tolerogenic macrophages. Of all cancers tested, PDAC showed the hig...

Descripción completa

Detalles Bibliográficos
Autores principales: Seifert, Adrian M., Reiche, Charlotte, Heiduk, Max, Tannert, Anna, Meinecke, Ann-Christin, Baier, Stephanie, von Renesse, Janusz, Kahlert, Christoph, Distler, Marius, Welsch, Thilo, Reissfelder, Christoph, Aust, Daniela E., Miller, George, Weitz, Jürgen, Seifert, Lena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142017/
https://www.ncbi.nlm.nih.gov/pubmed/32055023
http://dx.doi.org/10.1038/s41388-020-1186-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142017/
https://www.ncbi.nlm.nih.gov/pubmed/32055023
http://dx.doi.org/10.1038/s41388-020-1186-7

Ejemplares similares